Since the detection of HBeAg and anti-HBe is crucial for determining the phases of chronic hepatitis B (CHB) infection and is linked to active HBV replication and an increased risk of hepatocellular carcinoma (HCC), we assessed their presence in the chronic infection population. This evidence concerns the gene HBE1 and hepatocellular carcinoma.